Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy

Su Yi-Chia; Lin Pei-Chin; Yu Hsien-Chung; Wu Chih-Chien

首页> 外文期刊>European journal of gastroenterology and hepatology >Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy

【24h】

Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy

机译：乙型肝炎病毒重新激活患者乙型肝炎病毒感染接受化疗或免疫抑制治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background The role of antiviral prophylaxis before chemotherapy or immunosuppressive therapy to prevent hepatitis B virus (HBV) reactivation in patients with resolved HBV infection [hepatitis B surface antigen (HBsAg) negative, hepatitis B core antibody (anti-HBc) positive] is unclear. This study aimed to evaluate the efficacy of prophylactic antiviral therapy and outcomes of HBsAg-negative, anti-HBc-positive patients who received chemotherapy or immunosuppressive therapy.

机译：背景技术抗病毒预防在化疗或免疫抑制疗法前的作用，以预防乙型肝炎病毒（HBV）重新激活患者患者患者[乙型肝炎表面抗原（HBsAg）阴性，乙型肝炎核抗体（抗HBC）阳性]尚不清楚。本研究旨在评估预防抗病毒性治疗和接受化疗或免疫抑制治疗的抗HBC阳性患者的预防抗病疗法治疗和结果的疗效。

著录项

来源
《European journal of gastroenterology and hepatology》 |2018年第8期|共5页
作者
Su Yi-Chia; Lin Pei-Chin; Yu Hsien-Chung; Wu Chih-Chien;
展开▼
作者单位

Kaohsiung Vet Gen Hosp Dept Pharm Kaohsiung Taiwan;

Kaohsiung Vet Gen Hosp Dept Pharm Kaohsiung Taiwan;

Kaohsiung Vet Gen Hosp Dept Internal Med Div Gastroenterol Kaohsiung Taiwan;

Kaohsiung Vet Gen Hosp Dept Surg 386 Dazhong 1st Rd Kaohsiung Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
antiviral prophylaxis; hepatitis B virus reactivation; resolved hepatitis B virus infection;

机译：抗病毒预防;乙型肝炎病毒再激活;解决的乙型肝炎病毒感染;

相似文献

外文文献
中文文献
专利

1. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy [J] . Su Yi-Chia, Lin Pei-Chin, Yu Hsien-Chung, European journal of gastroenterology and hepatology . 2018,第8期

机译：乙型肝炎病毒重新激活患者乙型肝炎病毒感染接受化疗或免疫抑制治疗
2. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival [J] . Kai-Lin Chen, Jie Chen, Hui-Lan Rao, Cancer Communications . 2015,第3期

机译：接受利妥昔单抗化疗的已解决的乙型肝炎弥漫性大B细胞淋巴瘤患者的乙型肝炎病毒活化和肝炎：危险因素和生存
3. Is Antiviral Prophylaxis Necessary to Prevent Hepatitis B Virus (HBV) Reactivation in Patients With HBV-Resolved Infection Receiving Rituximab-Containing Chemotherapy? [J] . Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, Journal of Clinical Oncology . 2013,第35期

机译：接受利妥昔单抗化疗的乙肝病毒感染患者是否需要采取预防性预防措施来预防乙肝病毒（HBV）激活？
4. An Age-based Multiseale Mathematical Model of the Hepatitis C Virus Life-cycle During Infection and Therapy: Including Translation and Replication [C] . B.M. Quintela, J.M. Conway, J.M. Hyman Latin American Congress on Biomedical Engineering . 2017

机译：感染和治疗期间丙型肝炎病毒生命周期的基于年龄的多层数学模型：包括翻译和复制
5. Hepatitis virus reactivation in cancer patients undergoing cytotoxic chemotherapy: Incidences, associated factors and management. [D] . Yeo, Winnie. 2001

机译：接受细胞毒性化学疗法治疗的癌症患者的肝炎病毒再激活：发生率，相关因素和管理。
6. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival [O] . Kai-Lin Chen, Jie Chen, Hui-Lan Rao, 2015

机译：接受利妥昔单抗化疗的已解决的乙型肝炎弥漫性大B细胞淋巴瘤患者的乙型肝炎病毒活化和肝炎：危险因素和生存
7. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival [O] . 2015

机译：接受利妥昔单抗化疗的已解决的乙型肝炎弥漫性大B细胞淋巴瘤患者的乙型肝炎病毒活化和肝炎：危险因素和生存

Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy

摘要

著录项

相似文献

相关主题

期刊订阅